IQVIA Holdings | IQV - Net Income


IQVIA Holdings reported $274M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Accenture USD 2.34B 513.75M Mar/2026
Agilent USD 339M 34M Mar/2026
Bruker USD 3.5M 22.5M Mar/2026
Cardinal Health USD 399M 68M Mar/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Cigna USD 1.65B 420M Mar/2026
Cognizant Technology Solutions USD 662M 14M Mar/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
CVS Health USD 2.94B 0 Mar/2026
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -10M 136M Mar/2026
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
Elevance Health USD 1.46B 301M Jun/2026
Humana USD 1.19B 1.98B Mar/2026
IBM USD 1.22B 4.38B Mar/2026
Illumina USD 134M 200M Mar/2026
Infosys INR 85.09B 18.43B Mar/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Laboratory Of America USD 277.8M 113.1M Mar/2026
Malin Corporation EUR -1.1M 2.2M Dec/2023
McKesson USD 1.68B 496M Mar/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR -765K 4.89M Jun/2025
Pharma Mar EUR 1.53M 58.13M Mar/2026
Publicis EUR 793M 36M Jun/2026
Qiagen NV USD 107.83M 22.21M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Sartorius EUR 56.2M 37M Mar/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Tilray USD -44.93M 44.61M Sep/2025
Trubridge Inc USD -9.81M 4.76M Sep/2024
UnitedHealth USD 5.48B 796M Jun/2026
Veeva Systems USD 260.94M 16.73M Mar/2026
Veradigm USD -59.82M 74.35M Dec/2022
Waters USD -72M 297.21M Mar/2026
Zealand Pharma A/S -379.12M 25.12M Dec/2025
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026